‘Don’t Kill My Lyme – Just Get Me Better’ explains how the body responds to the disease and to conventional and alternative treatments
Featured Image for Lifestyle Healing Institute
NAPLES, Fla., June 15, 2022 (GLOBE NEWSWIRE) — Wyatt Palumbo struggled with chronic illness for months, with seven doctors prescribing 17 medications that failed to help. That experience led Palumbo to use his scientific training in chemical engineering and his problem-solving nature to found the Lifestyle Healing Institute.
Palumbo’s book Don’t Kill My Lyme – Just Get Me Better, on how the body responds to Lyme disease as a whole and how it responds to conventional and alternative solutions for this disease, was re-released in June 2022 with a new preface and concluding chapter.
The book embodies the philosophy of Lifestyle Healing Institute (LHI), a natural healthcare company and treatment center offering patients a new, effective therapy for chronic illness, chronic Lyme disease and symptoms resulting from overprescription. LHI has successfully treated more than 1,000 patients since its 2014 founding.
“Other fields of science need to be more actively involved in healthcare,” says Palumbo, a chemical engineer, a legal consultant on cases relating to Lyme disease, and an expert on biofilms and several chronic illnesses. “This is how we ensure that education, sound science and medicine converge to empower patients on their journey to get better.”
Palumbo’s first-hand experience with the debilitating effects of chronic illness led him to use his training in chemical engineering and his problem-solving nature to found LHI and patent its proprietary medical methods and systems.
Two years later, he wrote Don’t Kill My Lyme, to delineate a more efficient and integrative method of healing, disputing the notion your body must “kill” Lyme disease before it can heal from the illness. The book cites more than 100 publications and educates readers on how the body manages Lyme disease holistically, and also how the body handles current conventional and alternative treatments for this disease and others like it.
LHI’s baseline therapy for chronic illness utilizes scientifically validated therapies based on nearly 10 years of research, development and clinical data. Its multifaceted treatment program ensures client participation while also addressing each person’s unique healing needs.
The program begins by testing patients’ levels of over 100 biochemicals to pinpoint what their bodies need to facilitate healing and improve health. Treatments then calm the cells of the nervous system, returning them to their natural parasympathetic healing state.
Once a baseline is achieved, LHI layers multiple treatment modalities into the patient’s individualized program to support health at the cellular, system and whole-person level. LHI assesses the biochemical, emotional, psychological, and lifestyle contributions to a person’s illness and designs a multifaceted treatment program, with the client’s participation, to meet the person’s unique needs for healing.
All of LHI’s therapies are integrated within one program by a multidisciplinary team of doctors and healthcare practitioners with more than 150 years of clinical and medical experience. LHI’s patented holistic approach is delivered in both the clinic’s medical setting and the outdoor community setting of what the team calls its “pharm property,” an outdoor treatment center on several acres where patients and their families can directly experience therapies, take part in group treatments and integrate sustainable healing.
“I was eventually able to find help that worked for me, and so with LHI, we’re giving that back to more people,” Palumbo said. “We’re giving them a different way to solve their health issues and frees them from their chronic symptoms by addressing the whole person, starting with a chemical picture of their body to examining and changing their lifestyle.”
To learn more, visit https://lifestylehealinginstitute.com. Information about Don’t Kill My Lyme — Just Get Me Better, including how to order a copy, is also available on the LHI website. The book is also available on Amazon and other online retailers.
About Lifestyle Healing Institute
Lifestyle Healing Institute is a natural healthcare company and treatment center that strives to make medicine safer, more accessible and more effective. LHI’s patented Baseline Therapy has expanded into nearly 10 years of medical research, development and clinical data that is delivered within one program by an integrative team of doctors and healthcare providers with over 150 years of clinical and medical experience.
This content was issued through the press release distribution service at Newswire.com.
Featured Image for Lifestyle Healing Institute
Have an issue with your financial adviser or looking for a new one? Email questions and concerns to [email protected]
Leaving these accounts open could tarnish your golden years.
Nio (NYSE: NIO) stock spiked Monday morning, but it didn't take long for it to reverse course. The volatility shows just how dynamic the economic situation is in China. Shares of the Chinese EV maker jumped nearly 7% after the market opened, but by 12:40 p.m. ET, Nio stock was down by 1.6%.
A strong jobs report these days runs counter to the Fed’s wishes. The line of thought is that if the job market is still too hot, the Fed won’t be keen on loosening its tight monetary policy in the ongoing efforts to tame inflation. And this is a scenario the market is keen to avoid after a series of 75 basis-point hikes this year. But J.P. Morgan Asset Management chief strategist David Kelly thinks the latest numbers flatter to deceive and believes the way the data is reported distorts the real
As competition escalates for new savings customers, many financial institutions are promising high yields simply for becoming a customer and following various transaction requirements. Shopping around for a checking or savings account means finding a bank that fits with your financial lifestyle in terms of digital and mobile capabilities, as well as branch and ATM access, says McBride. “Avoid checking accounts that have balance requirements and monthly fees so you don’t unnecessarily strand money in a low-yielding account just to avoid fees,” adding that there are plenty of non-interest options out there that have no fees.
Top-line data from a phase IIb/III study shows that Anave's (AVXL) lead drug exhibited statistical and clinical improvement in cognition and function in patients with early Alzheimer's disease.
Shares of enterprise software giants Snowflake (NYSE: SNOW), Datadog (NASDAQ: DDOG), and MongoDB (NASDAQ: MDB) were plunging on Monday, down by 8.7%, 6.4%, and 9.4%, respectively, as of 3:06 p.m. ET. There wasn't much company-specific news today, although Snowflake reported earnings last week, and MongoDB will report tomorrow. Friday's strong jobs and wages report, combined with today's stronger-than-expected services Purchasing Managers' Index (PMI) reading, showed the economy may be stronger than generally thought — surprising, especially since recent financial results and guidance in the software industry have been less than stellar.
For Tesla (TSLA) in China, there's a bit of good news and some potential bad news.
A helicopter with important ties to Wichita has won a contract from the U.S. Army that could lead to more than 2,000 aircraft. The Army late Monday afternoon selected the V-280 Valor from the Bell unit of Textron Inc. as the winner of its Future Long Range Assault Aircraft program. The contract win will likely be challenged by the opposing team of Lockheed Martin Corp.’s (NYSE: LMT) and the Boeing Co. (NYSE: BA).
A roundup of recent banking and finance news across Greater Philadelphia: A coalition of 13 Republican state attorneys general wants to stop Vanguard Group from buying shares in U.S. utilities companies due to the investment manager’s environmental, social and governance policies. The attorneys general filed a motion last week to the Federal Energy Regulatory Commission requesting it block Vanguard’s purchase.
Yahoo Finance Live looks at cannabis-tied shares following President Biden's signing of a marijuana research bill.
In this article, we will discuss the 12 best undervalued energy stocks to buy. If you want to explore similar stocks, you can also take a look at 5 Best Undervalued Energy Stocks to Buy. 2022 has been the year for energy stocks. While all sectors of the economy fluctuated, the energy sector remained relatively […]
With a yield of 9.62%, the recently expired Series I bond was understandably popular. With interest rates rising, bond funds are down this year and banks continue to offer miserly rates on deposit accounts. So it's no wonder that a … Continue reading → The post It Pays to Procrastinate: The New 6.89% I bonds Will Beat the Old 9.62% Bonds in Just 4 Years appeared first on SmartAsset Blog.
New year, new Social Security rules.
Shares of telecom giant Lumen Technologies (NYSE: LUMN) plunged 25.7% in November, according to data from S&P Global Market Intelligence. It wasn't difficult to ascertain why Lumen fell last month: The company announced on its Nov. 2 earnings call that it suspended its generous dividend. In the third quarter, Lumen once again disappointed the markets, with revenue declining 10.2% and non-generally accepted accounting principles (adjusted) earnings per share of $0.14 missing estimates by a wide $0.21.
Many people wonder whether they should be investing in qualified or non-qualified dividends and what the differences are. The largest difference is in how each is taxed. To help you determine what stock paying dividends could have a place in … Continue reading → The post Qualified vs. Non-Qualified Dividends appeared first on SmartAsset Blog.
Even Warren Buffett has plenty of fingers in the pie.
GitLab Inc. (GTLB) delivered earnings and revenue surprises of 37.50% and 6.86%, respectively, for the quarter ended October 2022. Do the numbers hold clues to what lies ahead for the stock?
The founder of the bankrupt cryptocurrency exchange launched a media blitzkrieg to give his version of his downfall.
Elon Musk's group and its Chinese rivals are often among the choices of investors betting on electric vehicles.